NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Spatial Repellents for Malaria Control

WithdrawnNA

Sponsor: University of Notre Dame

Conditions: Malaria

Interventions: Transfluthrin - delivery by paid study personnel, Transfluthrin - delivery by voucher system, Transfluthrin - delivery by village health teams

Countries: Uganda

The primary objective of the study is to demonstrate and quantify the effectiveness of a spatial repellent (SR) product, in reducing malaria infection in humans under operational program conditions in a humanitarian assistance context. The design will be a cluster Randomized Control Trial (cRCT) representing an operational research study.

Eligibility overview

Sex: ALL

Age: 6 Months to 59 Months

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Children ≥ 6 months to ≤ 59 months
* Children ≥ 6 months to ≤ 59 months with Hb \> 7g/dL and no other serious illness
* Sleeps in cluster (i.e. study area) ≥ 90% of nights during any given month
* Not participating in another clinical trial investigating a vaccine, drug, medical device, or a medical procedure during the Trial
* Provision of informed consent form (ICF) signed by the parent(s) or guardian

Exclusion Criteria:

* Children \< 6 months and \> 59 months
* Children ≥ 6 months to ≤ 59 months with Hb ≤ 7g/dL with signs of other serious illness or Hb ≤ 7 g/dL with signs of clinical decompensation
* Sleeps in cluster (i.e. study area) \< 90% of nights during any given month
* Participating or planned participation in another clinical trial investigating a vaccine, drug, medical device, or a medical procedure during the trial
* No provision of ICF signed by the parent(s) or guardian

Locations (2)

Kampala, Uganda
Kampala, Uganda